Cannabix Technologies Inc. (BLOZF)
OTCMKTS · Delayed Price · Currency is USD
0.4103
-0.0297 (-6.75%)
Jan 8, 2026, 9:35 AM EST
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of $55.18 million as of January 8, 2026. Its market cap has increased by 105.34% in one year.
Market Cap
55.18M
Enterprise Value
54.08M
Revenue
87.80K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.41
Market Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 540.03K to 55.18M, an increase of 10,117.34%. That is a compound annual growth rate of 46.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 55.18M | 7.73% |
| Dec 31, 2025 | 51.22M | 100.00% |
| Dec 31, 2024 | 25.61M | 64.60% |
| Dec 29, 2023 | 15.56M | -43.24% |
| Dec 30, 2022 | 27.41M | -43.72% |
| Dec 31, 2021 | 48.71M | -34.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |